Philippe Rousselot
3 ta ish
Versailles Saint-Quentin-en-Yvelines University
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Michele Baccarani, Michael Deininger, Gianantonio Rosti +29
Sharh maqolaOchiq kirish20133 iqtibosABIPOSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial
Jane F. Apperley, Jörge E. Cortes, Elias Jabbour +21
MaqolaOchiq kirishChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibosABI